There will be a greater focus on surgical topics at the 2025 meeting of the American Society of Retina Specialists, compared with previous years, which reflects the need for balan ...

A bioresorbable hydrogel implant enabled continuous intraocular delivery of axitinib, a small-molecule VEGFR TKI, positioning TKIs as a potential alternative to repeated anti-VEGF intravitreal ...

Aimée K. Dailey, president of Government Health Benefits at Elevance Health | Authors | Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and ...

Ambient-stable microneedle patches are positioned as a route to reduce refrigeration dependence and simplify administration ...

Imaging for staging/surveillance was supported when predicted nodal metastasis risk is ≥15% and when high-risk features suggest occult regional disease or recurrence risk. Consensus/near-consensus ...

FDA authorization positions enlicitide as the first oral PCSK9 inhibitor, targeting PCSK9–LDLR interaction via macrocyclic peptide binding to deliver substantial LDL-C lowering in a daily pill ...

Monthly Eylea HD addresses a subset needing more frequent anti-VEGF than the ≥8‑week minimum used in PULSAR/PHOTON, including patients previously underperforming on aflibercept 8 mg q7–8w. ELARA is an ...

Specific brainstem inhibitory neurons help the brain filter out distractions by suppressing competing sensory signals, allowing mice (and presumably humans) to stay focused. Two researchers from Johns ...

Capital Rx is now Judi Rx, maintaining a transparent pass-through PBM model while aligning brand architecture with the Judi ...

Delinking PBM/GPO fees from list prices targets rebate-driven inflation that raises coinsurance and copays tied to inflated insulin list prices. Mandatory point-of-sale rebate pass-through and ...